Pfizer challenges NICE drug approval decisions

Pfizer and its Japanese partner Eisai Co. are preparing for a court fight June 25 challenging the U.K.'s National Institute for Clinical Health and Excellence. The companies oppose NICE's process for approving or rejecting drugs for government subsidies. NICE argues it is only seeking good value for the money spent on drugs.

View Full Article in:

Independent (London) (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
White Plains, NY
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ